Colonization With Multidrug-Resistant Organisms Among Healthy Adults in the Community Setting: Prevalence, Risk Factors, and Composition of Gut Microbiome
Overview
Authors
Affiliations
Background: The prevalence of colonization with multidrug-resistant organisms (MDROs) among healthy adults in the community is largely unknown. This study investigated the colonization rate of multidrug-resistant , methicillin-resistant (MRSA), and vancomycin-resistant enterococci (VRE) in the community in Taiwan, and compared the gut microbiota between MDRO carriers and non-carriers.
Methods: This prospective cohort study was conducted from March 2017 to February 2018 at the Hsin-Chu and Jin-Shan branches of National Taiwan University Hospital. Nasal swabs and stool samples were obtained from healthy adults attending a health examination to screen for MDROs. Bacteria isolates of MDROs were tested for antibiotic susceptibility and resistant genes. Relevant data were collected using a standardized questionnaire to evaluate the risk factors for MDROs carriage, and 16S rRNA metagenomics sequencing was performed to analyze gut microbiota.
Results: Among 187 participants, 4.6% (8/174) carried MRSA and 41.4% (77/186) carried third-generation cephalosporin-resistant (3GC-R) or . The carriage rate of AmpC beta-lactamases and ESBL-producing strains were 16.1 and 27.4%, respectively. No carbapenem-resistant (CRE) or VRE were detected. The dominant resistant gene of isolates was CTX-M-type (73%), while that of was AmpC beta-lactamases (80%). In the multivariate analysis, the significant risk factors for carrying 3GC-R or were being an employee of technology company A [adjusted odds ratio (aOR) 4.127; 95% confidence interval (CI) 1.824-9.336; = 0.001], and traveling to Southeast Asia in the past year (aOR 6.545; 95% CI 1.071-40.001; = 0.042). The gut microbiota analysis showed that the phylum and the family were significantly more abundant in 3GC-R and carriers.
Conclusion: A high rate of Taiwanese adults in the community carried 3GC-R , while no CRE or VRE colonization was noted. Compared with non-carriers, an expansion of in gut microbiota was found among 3GC-R carriers.
Colmenarejo C, Rodriguez-Jimenez C, Navarro F, Mateo A, Pellejero E, Belda-Moreno R JAC Antimicrob Resist. 2025; 7(1):dlaf008.
PMID: 39927311 PMC: 11806259. DOI: 10.1093/jacamr/dlaf008.
Waddepally V, Rabye S, Bashir R, Kandi V Cureus. 2025; 16(12):e75006.
PMID: 39749090 PMC: 11694048. DOI: 10.7759/cureus.75006.
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome.
Ghani R, Chrysostomou D, Roberts L, Pandiaraja M, Marchesi J, Mullish B Gut Microbes. 2024; 16(1):2423026.
PMID: 39499189 PMC: 11540080. DOI: 10.1080/19490976.2024.2423026.
Abera D, Negash A, Fentaw S, Mekonnen Y, Cataldo R, Wami A BMC Microbiol. 2024; 24(1):402.
PMID: 39390409 PMC: 11465526. DOI: 10.1186/s12866-024-03552-6.
Mendes B, Bortoli E, Zaleski C, Martinelli M, Pascoal V, Oliveira S BMC Oral Health. 2024; 24(1):533.
PMID: 38704542 PMC: 11069297. DOI: 10.1186/s12903-024-04295-6.